{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:05:33Z","timestamp":1793387133029,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-03965-3","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:14:39Z","timestamp":1750158879000},"page":"4301-4315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sex and gender disparities in hepatocellular carcinoma: insights into risk, diagnosis, and therapeutic outcomes"],"prefix":"10.1007","volume":"27","author":[{"given":"Tu Tuan","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy The","family":"Be","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh Dinh","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0824-6542","authenticated-orcid":false,"given":"Hoang Duc","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"3","key":"3965_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3965_CR2","first-page":"147","volume":"49","author":"KD Bertakis","year":"2000","unstructured":"Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147\u201352.","journal-title":"J Fam Pract"},{"issue":"2","key":"3965_CR3","doi-asserted-by":"publisher","first-page":"01","DOI":"10.35946\/arcr.v40.2.01","volume":"40","author":"AM White","year":"2020","unstructured":"White AM. Gender differences in the epidemiology of alcohol use and related harms in the United States. Alcohol Res Curr Rev. 2020;40(2):01.","journal-title":"Alcohol Res Curr Rev"},{"key":"3965_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/JHC.S212401","volume":"6","author":"PD Jones","year":"2019","unstructured":"Jones PD, Scheinberg AR, Muenyi V, Gonzalez-Diaz J, Martin PM, Kobetz E. Socioeconomic and survival differences among minorities with hepatocellular carcinoma in Florida. J Hepatocell Carcinoma. 2019;6:167\u201381.","journal-title":"J Hepatocell Carcinoma"},{"issue":"20","key":"3965_CR5","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1002\/cam4.4223","volume":"10","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Zhang X, Lu J, Liu S, Qian Y. Association between socioeconomic status and survival in patients with hepatocellular carcinoma. Cancer Med. 2021;10(20):7347\u201359.","journal-title":"Cancer Med"},{"issue":"4","key":"3965_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/apt.15917","volume":"52","author":"NE Rich","year":"2020","unstructured":"Rich NE, Murphy CC, Yopp AC, Tiro J, Marrero JA, Singal AG. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2020;52(4):701\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"3965_CR7","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1097\/TP.0000000000002196","volume":"102","author":"AM Allen","year":"2018","unstructured":"Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, et al. Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation. Transplantation. 2018;102(10):1710\u20136.","journal-title":"Transplantation"},{"issue":"7","key":"3965_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.1129","volume":"155","author":"JE Locke","year":"2020","unstructured":"Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D, et al. Quantifying sex-based disparities in liver allocation. JAMA Surg. 2020;155(7): e201129.","journal-title":"JAMA Surg"},{"key":"3965_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-6963-6-15","volume":"6","author":"AJ Viera","year":"2006","unstructured":"Viera AJ, Thorpe JM, Garrett JM. Effects of sex, age, and visits on receipt of preventive healthcare services: a secondary analysis of national data. BMC Health Serv Res. 2006;6:15.","journal-title":"BMC Health Serv Res"},{"key":"3965_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/0976-500X.107697","volume":"4","author":"J Singh","year":"2013","unstructured":"Singh J. Critical appraisal skills programme. CASP appraisal tools. J Pharmacol Pharmacother. 2013;4:76.","journal-title":"J Pharmacol Pharmacother"},{"issue":"1","key":"3965_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5.","journal-title":"Res Integr Peer Rev"},{"issue":"Suppl 1","key":"3965_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4\u201313.","journal-title":"Hepatology"},{"issue":"5","key":"3965_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/jgh3.12910","volume":"7","author":"WL Liou","year":"2023","unstructured":"Liou WL, Tan TJ, Chen K, Goh GB, Chang JP, Tan CK. Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades. JGH Open. 2023;7(5):377\u201386.","journal-title":"JGH Open"},{"issue":"3","key":"3965_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/CEJ.0000000000000428","volume":"27","author":"A Baecker","year":"2018","unstructured":"Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prevent. 2018;27(3):205\u201312.","journal-title":"Eur J Cancer Prevent"},{"issue":"11","key":"3965_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/cncr.29971","volume":"122","author":"OV Makarova-Rusher","year":"2016","unstructured":"Makarova-Rusher OV, Altekruse SF, McNeel TS, Ulahannan S, Duffy AG, Graubard BI, et al. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer. 2016;122(11):1757\u201365.","journal-title":"Cancer"},{"issue":"9","key":"3965_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jvir.2016.06.035","volume":"27","author":"MP Kohi","year":"2016","unstructured":"Kohi MP. Gender-related differences in hepatocellular carcinoma: does sex matter? J Vasc Intervent Radiol. 2016;27(9):1338\u201341.","journal-title":"J Vasc Intervent Radiol"},{"issue":"3","key":"3965_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/bjc.1993.116","volume":"67","author":"A Tavani","year":"1993","unstructured":"Tavani A, Negri E, Parazzini F, Franceschi S, La Vecchia C. Female hormone utilisation and risk of hepatocellular carcinoma. Br J Cancer. 1993;67(3):635\u20137.","journal-title":"Br J Cancer"},{"issue":"2","key":"3965_CR18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2012.03.004","volume":"57","author":"VW Keng","year":"2012","unstructured":"Keng VW, Largaespada DA, Villanueva A. Why men are at higher risk for hepatocellular carcinoma? J Hepatol. 2012;57(2):453\u20134.","journal-title":"J Hepatol"},{"issue":"3","key":"3965_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1557988311425853","volume":"6","author":"JL Davis","year":"2012","unstructured":"Davis JL, Buchanan KL, Katz RV, Green BL. Gender differences in cancer screening beliefs, behaviors, and willingness to participate: implications for health promotion. Am J Mens Health. 2012;6(3):211\u20137.","journal-title":"Am J Mens Health"},{"issue":"1","key":"3965_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2016-000107","volume":"3","author":"MR Ladenheim","year":"2016","unstructured":"Ladenheim MR, Kim NG, Nguyen P, Le A, Stefanick ML, Garcia G, et al. Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterol. 2016;3(1): e000107.","journal-title":"BMJ Open Gastroenterol"},{"key":"3965_CR21","first-page":"53","volume":"10","author":"JK Ho","year":"2024","unstructured":"Ho JK, Thurairajah PH, Leo J, Huang DQ, Fan KH. Sex differences in hepatocellular carcinoma. Hepatoma Res. 2024;10:53.","journal-title":"Hepatoma Res"},{"issue":"1","key":"3965_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12072-007-9041-2","volume":"2","author":"SC Buch","year":"2008","unstructured":"Buch SC, Kondragunta V, Branch RA, Carr BI. Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hep Int. 2008;2(1):95\u2013101.","journal-title":"Hep Int"},{"issue":"18","key":"3965_CR23","first-page":"5106","volume":"60","author":"K Tanaka","year":"2000","unstructured":"Tanaka K, Sakai H, Hashizume M, Hirohata T. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Can Res. 2000;60(18):5106\u201310.","journal-title":"Can Res"},{"issue":"5","key":"3965_CR24","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1002\/cam4.4551","volume":"11","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 2022;11(5):1310\u201323.","journal-title":"Cancer Med"},{"issue":"7","key":"3965_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41416-018-0007-z","volume":"118","author":"JL Petrick","year":"2018","unstructured":"Petrick JL, Campbell PT, Koshiol J, Thistle JE, Andreotti G, Beane-Freeman LE, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005\u201312.","journal-title":"Br J Cancer"},{"issue":"6","key":"3965_CR26","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.23527","volume":"51","author":"MS Ascha","year":"2010","unstructured":"Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972\u20138.","journal-title":"Hepatology"},{"issue":"6","key":"3965_CR27","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1002\/hep.26986","volume":"59","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology7. 2014;59(6):2188\u201395.","journal-title":"Hepatology7."},{"issue":"12","key":"3965_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.48946","volume":"7","author":"T Yan","year":"2024","unstructured":"Yan T, Zhang X, Wong T, Cheung R, Nguyen MH. Sex differences in adverse liver and nonliver outcomes in steatotic liver disease. JAMA Netw Open. 2024;7(12): e2448946.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"3965_CR29","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1136\/gutjnl-2021-326050","volume":"71","author":"F Ji","year":"2022","unstructured":"Ji F, Zhang J, Liu N, Gu Y, Zhang Y, Huang P, et al. Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression. Gut. 2022;71(11):2313\u201324.","journal-title":"Gut"},{"issue":"11","key":"3965_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/jvh.12728","volume":"24","author":"JR Kramer","year":"2017","unstructured":"Kramer JR, El-Serag HB, Taylor TJ, White DL, Asch SM, Frayne SM, et al. Hepatitis C virus-related complications are increasing in women veterans: a national cohort study. J Viral Hepatitis. 2017;24(11):955\u201365.","journal-title":"J Viral Hepatitis"},{"issue":"2","key":"3965_CR31","first-page":"172","volume":"12","author":"Y Abboud","year":"2024","unstructured":"Abboud Y, Ismail M, Khan H, Medina-Morales E, Alsakarneh S, Jaber F, et al. Hepatocellular carcinoma incidence and mortality in the USA by sex, age, and race: a nationwide analysis of two decades. J Clin Transl Hepatol. 2024;12(2):172\u201381.","journal-title":"J Clin Transl Hepatol"},{"issue":"6","key":"3965_CR32","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.e1.","journal-title":"Gastroenterology"},{"issue":"4","key":"3965_CR33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.32758","volume":"77","author":"DJH Tan","year":"2023","unstructured":"Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, et al. Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH. Hepatology. 2023;77(4):1150\u201363.","journal-title":"Hepatology"},{"issue":"4","key":"3965_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1155\/2008\/243607","volume":"22","author":"PC Hsu","year":"2008","unstructured":"Hsu PC, Buxton JA, Tu AW, Hill WD, Yu A, Krajden M. Publicly funded pegylated interferon-alpha treatment in British Columbia: disparities in treatment patterns for people with hepatitis C. Can J Gastroenterol. 2008;22(4):359\u201364.","journal-title":"Can J Gastroenterol"},{"key":"3965_CR35","doi-asserted-by":"publisher","first-page":"12732","DOI":"10.3389\/ti.2024.12732","volume":"37","author":"M Tejedor","year":"2024","unstructured":"Tejedor M, Neria F, De La Rosa G, Almohalla \u00c1lvarez C, Padilla M, Bosc\u00e0 Robledo A, et al. Women are also disadvantaged in accessing transplant outside the United States: analysis of the Spanish Liver Transplantation Registry. Transpl Int. 2024;37:12732.","journal-title":"Transpl Int"},{"issue":"8","key":"3965_CR36","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1007\/s00268-021-06091-7","volume":"45","author":"M Darden","year":"2021","unstructured":"Darden M, Parker G, Monlezun D, Anderson E, Buell JF. Race and gender disparity in the surgical management of hepatocellular cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) Program Registry. World J Surg. 2021;45(8):2538\u201345.","journal-title":"World J Surg"},{"issue":"11","key":"3965_CR37","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/jamasurg.2024.3498","volume":"159","author":"DC Cron","year":"2024","unstructured":"Cron DC, Mazur RD, Bhan I, Adler JT, Yeh H. Sex and size disparities in access to liver transplant for patients with hepatocellular carcinoma. JAMA Surg. 2024;159(11):1291\u20138.","journal-title":"JAMA Surg"},{"issue":"2","key":"3965_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.aogh.2017.02.002","volume":"83","author":"K Xu","year":"2017","unstructured":"Xu K, Watanabe-Galloway S, Rochling FA, Zhang J, Farazi PA, Peng H, et al. Practice, knowledge, and barriers for screening of hepatocellular carcinoma among high-risk Chinese patients. Ann Glob Health. 2017;83(2):281\u201392.","journal-title":"Ann Glob Health"},{"key":"3965_CR39","doi-asserted-by":"publisher","first-page":"B074","DOI":"10.1158\/1538-7755.DISP24-B074","volume":"33","author":"B Zovich","year":"2024","unstructured":"Zovich B, Borondy-Jenkins F, Block S, Moraras K, Chen T, Cohen C. Abstract B074: qualitative assessment of knowledge gaps and barriers to Hepatitis B and liver cancer screening in high-risk U.S. communities. Cancer Epidemiol Biomarkers Prevent. 2024;33:B074.","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"4","key":"3965_CR40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2007.03.015","volume":"47","author":"S Maheshwari","year":"2007","unstructured":"Maheshwari S, Sarraj A, Kramer J, El-Serag HB. Oral contraception and the risk of hepatocellular carcinoma. J Hepatol. 2007;47(4):506\u201313.","journal-title":"J Hepatol"},{"issue":"6","key":"3965_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/01.mcg.0000165670.25272.46","volume":"39","author":"CM Lam","year":"2005","unstructured":"Lam CM, Yong JL, Chan AO, Ng KK, Poon RT, Liu CL, et al. Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related? J Clin Gastroenterol. 2005;39(6):533\u20139.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"3965_CR42","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"issue":"2","key":"3965_CR43","doi-asserted-by":"publisher","DOI":"10.12771\/emj.2024.e17","volume":"47","author":"S Joo","year":"2024","unstructured":"Joo S, Kim W. Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review. Ewha Med J. 2024;47(2): e17.","journal-title":"Ewha Med J"},{"issue":"32","key":"3965_CR44","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.3748\/wjg.v13.i32.4295","volume":"13","author":"I Shimizu","year":"2007","unstructured":"Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW, He JH, et al. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol. 2007;13(32):4295\u2013305.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3965_CR45","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1038\/s41598-024-52884-w","volume":"14","author":"BJB Beudeker","year":"2024","unstructured":"Beudeker BJB, Guha R, Stoyanova K, Jan NM, de Man RA, Sprengers D, et al. Cryptogenic non-cirrhotic HCC: clinical, prognostic and immunologic aspects of an emerging HCC etiology. Sci Rep. 2024;14(1):4302.","journal-title":"Sci Rep"},{"issue":"3","key":"3965_CR46","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","volume":"63","author":"F Piscaglia","year":"2016","unstructured":"Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, et al. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology. 2016;63(3):827\u201338.","journal-title":"Hepatology"},{"issue":"9","key":"3965_CR47","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/cancers13092085","volume":"13","author":"G Carruba","year":"2021","unstructured":"Carruba G. Estrogens in hepatocellular carcinoma: friends or foes? Cancers. 2021;13(9):2085.","journal-title":"Cancers"},{"issue":"1\u20132","key":"3965_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0303-7207(02)00096-5","volume":"193","author":"N De Maria","year":"2002","unstructured":"De Maria N, Manno M, Villa E. Sex hormones and liver cancer. Mol Cell Endocrinol. 2002;193(1\u20132):59\u201363.","journal-title":"Mol Cell Endocrinol"},{"key":"3965_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1196\/annals.1386.044","volume":"1089","author":"L Giannitrapani","year":"2006","unstructured":"Giannitrapani L, Soresi M, La Spada E, Cervello M, D\u2019Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228\u201336.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"3965_CR50","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/ERC-13-0283","volume":"21","author":"WL Ma","year":"2014","unstructured":"Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer. 2014;21(3):R165\u201382.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"3965_CR51","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1084\/jem.20181288","volume":"216","author":"E Manieri","year":"2019","unstructured":"Manieri E, Herrera-Melle L, Mora A, Tomas-Loba A, Leiva-Vega L, Fernandez DI, et al. Adiponectin accounts for gender differences in hepatocellular carcinoma incidence. J Exp Med. 2019;216(5):1108\u201319.","journal-title":"J Exp Med"},{"issue":"7","key":"3965_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.3390\/biology12070984","volume":"12","author":"R Nevola","year":"2023","unstructured":"Nevola R, Tortorella G, Rosato V, Rinaldi L, Imbriani S, Perillo P, et al. Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma. Biology. 2023;12(7):984.","journal-title":"Biology"},{"issue":"39","key":"3965_CR53","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.3748\/wjg.14.5945","volume":"14","author":"M Kalra","year":"2008","unstructured":"Kalra M, Mayes J, Assefa S, Kaul AK, Kaul R. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol. 2008;14(39):5945\u201361.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3965_CR54","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1084\/jem.20190441","volume":"216","author":"TF Greten","year":"2019","unstructured":"Greten TF. Gender disparity in HCC: is it the fat and not the sex? J Exp Med. 2019;216(5):1014\u20135.","journal-title":"J Exp Med"},{"issue":"5834","key":"3965_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u20134.","journal-title":"Science"},{"key":"3965_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1479-5876-12-93","volume":"12","author":"L Shi","year":"2014","unstructured":"Shi L, Feng Y, Lin H, Ma R, Cai X. Role of estrogen in hepatocellular carcinoma: is inflammation the key? J Transl Med. 2014;12:93.","journal-title":"J Transl Med"},{"issue":"1\u20132","key":"3965_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cell.2011.11.026","volume":"148","author":"Z Li","year":"2012","unstructured":"Li Z, Tuteja G, Schug J, Kaestner KH. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell. 2012;148(1\u20132):72\u201383.","journal-title":"Cell"},{"issue":"1","key":"3965_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v24.i1.1","volume":"24","author":"OA Sukocheva","year":"2018","unstructured":"Sukocheva OA. Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet? World J Gastroenterol. 2018;24(1):1\u20134.","journal-title":"World J Gastroenterol"},{"key":"3965_CR59","doi-asserted-by":"publisher","first-page":"66","DOI":"10.20517\/2394-5079.2018.87","volume":"4","author":"EM Wu","year":"2018","unstructured":"Wu EM, Wong LL, Hernandez BY, Ji JF, Jia W, Kwee SA, et al. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease\/steatohepatitis and liver transplantation. Hepatoma Res. 2018;4:66.","journal-title":"Hepatoma Res"},{"issue":"4","key":"3965_CR60","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"JD Yang","year":"2014","unstructured":"Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, et al. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology. 2014;59(4):1406\u201314.","journal-title":"Hepatology"},{"issue":"11","key":"3965_CR61","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.cgh.2017.05.036","volume":"15","author":"MM Hassan","year":"2017","unstructured":"Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, et al. Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2017;15(11):1791\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"3965_CR62","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1158\/1055-9965.EPI-20-1088","volume":"30","author":"YN Flores","year":"2021","unstructured":"Flores YN, Datta GD, Yang L, Corona E, Devineni D, Glenn BA, et al. Disparities in hepatocellular carcinoma incidence, stage, and survival: a large population-based study. Cancer Epidemiol Biomarkers Prevent. 2021;30(6):1193\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"key":"3965_CR63","doi-asserted-by":"publisher","first-page":"1433540","DOI":"10.3389\/fphar.2024.1433540","volume":"15","author":"L Su","year":"2024","unstructured":"Su L, Luo H, Yan Y, Yang Z, Lu J, Xu D, et al. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma. Front Pharmacol. 2024;15:1433540.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3965_CR64","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.23163","volume":"50","author":"SH Wang","year":"2009","unstructured":"Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology. 2009;50(5):1392\u2013402.","journal-title":"Hepatology"},{"issue":"1","key":"3965_CR65","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1038\/s41598-019-43376-3","volume":"9","author":"TMK Motawi","year":"2019","unstructured":"Motawi TMK, Sadik NAH, Sabry D, Shahin NN, Fahim SA. rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in Egyptians. Sci Rep. 2019;9(1):6868.","journal-title":"Sci Rep"},{"issue":"11","key":"3965_CR66","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.2174\/13816128113199990533","volume":"20","author":"L Rongrui","year":"2014","unstructured":"Rongrui L, Na H, Zongfang L, Fanpu J, Shiwen J. Epigenetic mechanism involved in the HBV\/HCV-related hepatocellular carcinoma tumorigenesis. Curr Pharm Des. 2014;20(11):1715\u201325.","journal-title":"Curr Pharm Des"},{"issue":"33","key":"3965_CR67","doi-asserted-by":"publisher","first-page":"34941","DOI":"10.18632\/oncotarget.5472","volume":"6","author":"FY Huang","year":"2015","unstructured":"Huang FY, Wong DK, Seto WK, Lai CL, Yuen MF. Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development. Oncotarget. 2015;6(33):34941\u201352.","journal-title":"Oncotarget"},{"key":"3965_CR68","doi-asserted-by":"publisher","first-page":"1431211","DOI":"10.3389\/fimmu.2024.1431211","volume":"15","author":"G Du","year":"2024","unstructured":"Du G, Dou C, Sun P, Wang S, Liu J, Ma L. Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy. Front Immunol. 2024;15:1431211.","journal-title":"Front Immunol"},{"issue":"10\u201311","key":"3965_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.clinbiochem.2016.01.025","volume":"49","author":"SS Kim","year":"2016","unstructured":"Kim SS, Cho HJ, Lee HY, Park JH, Noh CK, Shin SJ, et al. Genetic polymorphisms in the Wnt\/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma. Clin Biochem. 2016;49(10\u201311):792\u2013801.","journal-title":"Clin Biochem"},{"issue":"1","key":"3965_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/humupd\/dmw037","volume":"23","author":"GC Zhong","year":"2016","unstructured":"Zhong GC, Liu Y, Chen N, Hao FB, Wang K, Cheng JH, et al. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies. Hum Reprod Update. 2016;23(1):126\u201338.","journal-title":"Hum Reprod Update"},{"issue":"23","key":"3965_CR71","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1002\/cncr.28912","volume":"120","author":"D Yang","year":"2014","unstructured":"Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, et al. Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis. Cancer. 2014;120(23):3707\u201316.","journal-title":"Cancer"},{"issue":"5","key":"3965_CR72","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.cgh.2013.09.053","volume":"12","author":"P Gopal","year":"2014","unstructured":"Gopal P, Yopp AC, Waljee AK, Chiang J, Nehra M, Kandunoori P, et al. Factors that affect accuracy of alpha-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12(5):870\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"3965_CR73","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.3748\/wjg.v10.i11.1547","volume":"10","author":"P Tangkijvanich","year":"2004","unstructured":"Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10(11):1547\u201350.","journal-title":"World J Gastroenterol"},{"issue":"10250","key":"3965_CR74","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396(10250):565\u201382.","journal-title":"Lancet"},{"issue":"1","key":"3965_CR75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/hep.23615","volume":"52","author":"JA Davila","year":"2010","unstructured":"Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010;52(1):132\u201341.","journal-title":"Hepatology"},{"issue":"3","key":"3965_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329\u201338.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"3965_CR77","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cgh.2019.04.043","volume":"18","author":"NE Rich","year":"2020","unstructured":"Rich NE, Yopp AC, Singal AG, Murphy CC. Hepatocellular carcinoma incidence is decreasing among younger adults in the United States. Clin gastroenterol hepatol. 2020;18(1):242-8.e5.","journal-title":"Clin gastroenterol hepatol"},{"issue":"40","key":"3965_CR78","doi-asserted-by":"publisher","first-page":"68131","DOI":"10.18632\/oncotarget.19245","volume":"8","author":"P Liu","year":"2017","unstructured":"Liu P, Xie SH, Hu S, Cheng X, Gao T, Zhang C, et al. Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States. Oncotarget. 2017;8(40):68131\u20137.","journal-title":"Oncotarget"},{"issue":"10","key":"3965_CR79","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/MEG.0b013e32831a86f8","volume":"21","author":"F Farinati","year":"2009","unstructured":"Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnu L, et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009;21(10):1212\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"3965_CR80","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.14309\/ajg.0000000000000643","volume":"115","author":"M Phipps","year":"2020","unstructured":"Phipps M, Livanos A, Guo A, Pomenti S, Yeh J, Dakhoul L, et al. Gender matters: characteristics of hepatocellular carcinoma in women from a large, multicenter study in the United States. Am J Gastroenterol. 2020;115(9):1486\u201395.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"3965_CR81","doi-asserted-by":"publisher","first-page":"543","DOI":"10.6004\/jnccn.2015.0074","volume":"13","author":"N Patel","year":"2015","unstructured":"Patel N, Yopp AC, Singal AG. Diagnostic delays are common among patients with hepatocellular carcinoma. J National Comprehen Cancer Network. 2015;13(5):543\u20139.","journal-title":"J National Comprehen Cancer Network"},{"issue":"3","key":"3965_CR82","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3748\/wjg.v13.i3.414","volume":"13","author":"K Uka","year":"2007","unstructured":"Uka K, Aikata H, Takaki S, Shirakawa H, Jeong SC, Yamashina K, et al. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007;13(3):414\u201320.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3965_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/hep.29485","volume":"67","author":"L Kulik","year":"2018","unstructured":"Kulik L, Heimbach JK, Zaiem F, Almasri J, Prokop LJ, Wang Z, et al. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta-analysis. Hepatology. 2018;67(1):381\u2013400.","journal-title":"Hepatology"},{"issue":"3","key":"3965_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1440-1746.2003.02936.x","volume":"18","author":"K Dohmen","year":"2003","unstructured":"Dohmen K, Shigematsu H, Irie K, Ishibashi H. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18(3):267\u201372.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"3965_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100982","volume":"6","author":"L Balcar","year":"2024","unstructured":"Balcar L, Scheiner B, Fulgenzi CAM, D\u2019Alessio A, Pomej K, Roig MB, et al. A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma. JHEP Rep. 2024;6(2): 100982.","journal-title":"JHEP Rep"},{"issue":"4","key":"3965_CR86","first-page":"545","volume":"15","author":"M Sarkar","year":"2016","unstructured":"Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N. Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016;15(4):545\u20139.","journal-title":"Ann Hepatol"},{"issue":"1","key":"3965_CR87","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12885-019-5453-3","volume":"19","author":"MW Lai","year":"2019","unstructured":"Lai MW, Chu YD, Lin CL, Chien RN, Yeh TS, Pan TL, et al. Is there a sex difference in postoperative prognosis of hepatocellular carcinoma? BMC Cancer. 2019;19(1):250.","journal-title":"BMC Cancer"},{"issue":"8","key":"3965_CR88","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.cgh.2017.02.033","volume":"15","author":"LD Nephew","year":"2017","unstructured":"Nephew LD, Goldberg DS, Lewis JD, Abt P, Bryan M, Forde KA. Exception points and body size contribute to gender disparity in liver transplantation. Clin Gastroenterol Hepatol. 2017;15(8):1286-93.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3965_CR89","first-page":"379","volume":"36","author":"N Nagasue","year":"1989","unstructured":"Nagasue N, Galizia G, Yukaya H, Kohno H, Chang YC, Hayashi T, et al. Better survival in women than in men after radical resection of hepatocellular carcinoma. Hepatogastroenterology. 1989;36(5):379\u201383.","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"3965_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100695","volume":"27","author":"T Liang","year":"2022","unstructured":"Liang T, He Y, Mo S, Chen Z, Liao X, Zhou X, et al. Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy. Ann Hepatol. 2022;27(3): 100695.","journal-title":"Ann Hepatol"},{"issue":"4","key":"3965_CR91","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2014.11.023","volume":"62","author":"M Sarkar","year":"2015","unstructured":"Sarkar M, Watt KD, Terrault N, Berenguer M. Outcomes in liver transplantation: does sex matter? J Hepatol. 2015;62(4):946\u201355.","journal-title":"J Hepatol"},{"issue":"7","key":"3965_CR92","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001642","volume":"10","author":"JH Koh","year":"2024","unstructured":"Koh JH, Chee D, Ng CH, Wijarnpreecha K, Muthiah M, Tan DJH, et al. Sex-based disparities in liver transplantation for hepatocellular carcinoma and the impact of the growing burden of NASH. Transplant Direct. 2024;10(7): e1642.","journal-title":"Transplant Direct"},{"issue":"3","key":"3965_CR93","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jhep.2010.09.001","volume":"54","author":"F Durand","year":"2011","unstructured":"Durand F. The quest for equity in liver transplantation: another lesson learned from women. J Hepatol. 2011;54(3):401\u20132.","journal-title":"J Hepatol"},{"issue":"3","key":"3965_CR94","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1600-6143.2007.01666.x","volume":"7","author":"E Cholongitas","year":"2007","unstructured":"Cholongitas E, Marelli L, Kerry A, Goodier DW, Nair D, Thomas M, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores\u2013a systematic bias. Am J Transplant. 2007;7(3):685\u201392.","journal-title":"Am J Transplant"},{"issue":"36","key":"3965_CR95","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.4254\/wjh.v9.i36.1346","volume":"9","author":"L Sobotka","year":"2017","unstructured":"Sobotka L, Hinton A, Conteh L. Women receive more inpatient resections and ablations for hepatocellular carcinoma than men. World J Hepatol. 2017;9(36):1346\u201351.","journal-title":"World J Hepatol"},{"issue":"7","key":"3965_CR96","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/apt.12450","volume":"38","author":"D Tan","year":"2013","unstructured":"Tan D, Yopp A, Beg MS, Gopal P, Singal AG. Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2013;38(7):703\u201312.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"3965_CR97","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","volume":"29","author":"A Cherubini","year":"2023","unstructured":"Cherubini A, Ostadreza M, Jamialahmadi O, Pelusi S, Rrapaj E, Casirati E, et al. Interaction between estrogen receptor-alpha and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Nat Med. 2023;29(10):2643\u201355.","journal-title":"Nat Med"},{"issue":"7","key":"3965_CR98","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/SMJ.0b013e31821f8ab0","volume":"104","author":"GX Ma","year":"2011","unstructured":"Ma GX, Lee S, Wang M, Tan Y, Gao W, Ma X, et al. Role of sociocultural factors in hepatitis B screening among Asian Americans. South Med J. 2011;104(7):466\u201372.","journal-title":"South Med J"},{"key":"3965_CR99","doi-asserted-by":"publisher","first-page":"1377096","DOI":"10.3389\/fpubh.2024.1377096","volume":"12","author":"B Zovich","year":"2024","unstructured":"Zovich B, Block SJ, Borondy-Jenkins F, Moraras K, Chen T, Adedokun R, et al. The role of culturally appropriate interpersonal communication strategies to reduce hepatitis B and liver cancer disparities. Front Public Health. 2024;12:1377096.","journal-title":"Front Public Health"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03965-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-03965-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-03965-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:04:18Z","timestamp":1763568258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-03965-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":99,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3965"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-03965-3","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}